⌘ Services

Custom Antisense Oligonucleotide (ASO) Synthesis Services

Custom ASO synthesis for three core product service platforms: Gapmer ASO, Steric-Blocking ASO, and Splice-Switching ASO. Bio-Synthesis supports advanced RNA modification strategies, scalable production, and rigorous quality control for research through GLP/GMP-aligned development workflows.

Gapmer ASO Steric-Blocking ASO Splice-Switching ASO 100 g/batch ISO 9001:2015 / ISO 13485:2016 45+ Years of Expertise U.S.A. Facilities - Texas GLP/GMP-Aligned

Custom ASO Synthesis Overview

Antisense oligonucleotide (ASO) synthesis enables precise, sequence-specific modulation of RNA for gene silencing, functional inhibition, and transcript engineering. ASOs are short, synthetic nucleic acid analogs designed to bind complementary RNA targets and control gene expression through multiple mechanisms, including RNase H-mediated degradation, steric blocking, and splice modulation.

Bio-Synthesis provides advanced custom ASO synthesis services supporting three core product platforms: Gapmer ASO, Steric-Blocking ASO, and Splice-Switching ASO. Each ASO can be fully customized using a broad range of base, sugar, backbone, linkage, terminal, and conjugation modifications, enabling optimized performance across research, translational, and therapeutic applications.

With over 45 years of oligonucleotide expertise, ISO-certified quality systems, and U.S.-based manufacturing facilities in Texas, Bio-Synthesis supports projects from early discovery through development-scale production, including custom synthesis up to 100 g/batch with GLP/GMP-aligned workflows.

Why Bio-Synthesis for ASO development?
  • Broad modification capability including thousands of standard, advanced, and exotic chemistries
  • Flexible ASO design across gapmer, steric-blocking, and splice-switching platforms
  • Integrated support from sequence design to synthesis, purification, QC, and conjugation
  • Scalable synthesis with high purity and rigorous analytical validation
  • Technical consultation for complex or specialized ASO workflows

Scale

From screening to larger development projects, Bio-Synthesis supports custom ASO synthesis up to 100 g/batch, depending on sequence, chemistry, purity, and documentation requirements.

Chemistry

Extensive modification capabilities across base, sugar, backbone, linkage, terminal, and conjugation chemistries, including thousands of standard and custom options.

Quality Control

Analytical validation options include LC-MS, HPLC, purity analysis, OD260 quantification, and custom release testing tailored to project requirements.

OEM & Development

ISO 9001:2015 / ISO 13485:2016 systems, GLP/GMP-aligned workflows, documentation support, tech transfer support, and U.S.-based manufacturing in Texas.

Core ASO Product Services

Gapmer ASO →

RNase H-mediated RNA knockdown

Gapmer ASOs use a central DNA gap flanked by chemically modified wings. After binding target RNA, the DNA/RNA duplex recruits RNase H1, resulting in targeted RNA cleavage.

  • mRNA knockdown and gene silencing
  • Target validation and functional genomics
  • Optimized gap-wing architecture

Steric-Blocking ASO →

Non-cleaving RNA functional inhibition

Steric-blocking ASOs bind RNA and physically interfere with translation, RNA-protein interactions, or regulatory RNA elements without recruiting RNase H.

  • Translation inhibition
  • miRNA inhibition / antimiR workflows
  • RNA-protein interaction blocking

Splice-Switching ASO →

Pre-mRNA splicing control

Splice-switching ASOs are specialized steric-blocking oligos that redirect splicing machinery to promote exon skipping, exon inclusion, or transcript isoform changes.

  • Exon skipping or exon inclusion
  • Transcript engineering
  • Precision RNA modulation

Antisense Oligonucleotide (ASO) Technology & Benefits

Antisense oligonucleotide (ASO) technology is a programmable RNA-targeting approach that uses short synthetic oligonucleotides to bind complementary RNA sequences and modulate gene expression. Depending on the ASO design, chemistry, and target site, ASOs can trigger RNA degradation, block RNA function, or redirect pre-mRNA splicing.

ASOs are especially useful because they can target both cytoplasmic and nuclear RNA, including mRNA, pre-mRNA splice sites, regulatory RNA elements, and selected noncoding RNAs. This makes ASOs a flexible platform for functional genomics, target validation, pathway analysis, and therapeutic oligonucleotide development.

ASO Technology Mechanisms & Benefits

Antisense oligonucleotide ASO mechanisms and benefits showing targeted RNA degradation, steric blocking, splice modulation, and miRNA inhibition

ASO mechanism overview. Antisense oligonucleotides support targeted RNA degradation, steric blocking, splice modulation, and miRNA inhibition through sequence-specific targeting and chemical modification strategies.

ASO design flexibility: By selecting the appropriate chemistry and architecture, antisense oligonucleotides can be optimized for RNA degradation, steric blocking, splice modulation, or regulatory RNA targeting—enabling precise control of gene expression across a wide range of applications.

Benefit How ASO Technology Helps Best-Fit Service
Programmable Specificity ASOs are designed by sequence, allowing direct targeting of selected RNA regions. Gapmer ASO, Steric-Blocking ASO, Splice-Switching ASO
Multiple Mechanisms The same oligonucleotide platform can support degradation, functional blocking, or splice modulation by changing design and chemistry. Mechanism-specific ASO synthesis
Nuclear RNA Access ASOs can target pre-mRNA and nuclear RNA regions, including splice junctions and regulatory elements. Splice-Switching ASO and steric-blocking designs
Chemical Optimization Backbone, sugar, base, linkage, terminal, and conjugation modifications can improve stability, affinity, potency, and delivery. Modified ASO synthesis and add-on services
Research to Development Scale Projects can move from discovery and screening quantities to larger qualified ASO batches depending on sequence, chemistry, QC, and documentation requirements. Custom ASO synthesis up to 100 g/batch

Custom optimization available: ASO performance can be tuned through sequence selection, gapmer architecture, wing chemistry, PS linkage strategy, splice-site targeting, purification grade, delivery conjugation, and custom QC requirements.

Allele-Specific and SNP-Selective ASO Design

Allele-specific antisense oligonucleotides are designed to preferentially recognize one RNA allele over another, such as a disease-associated variant versus its wild-type counterpart. Unlike a separate ASO mechanism, allele selectivity is a design objective that can be pursued with gapmer, steric-blocking, or splice-switching architectures. Selectivity must be established experimentally; a single-base mismatch does not automatically ensure allele-specific activity.

Allele-Specific Targeting & SNP Discrimination

Candidate ASOs can be positioned across a single-nucleotide polymorphism (SNP) or pathogenic variant to favor binding to the intended transcript. Compare the variant and reference sequences, assess nearby polymorphisms, and evaluate both alleles in matched assays.

A centrally located mismatch may help discrimination in some designs, but the optimal position depends on sequence context, chemistry, target structure, and mechanism.

Chemical Modification Strategies

LNA can increase affinity and may improve mismatch discrimination when carefully positioned. 2′-MOE and 2′-OMe can tune binding and nuclease resistance. Phosphorothioate (PS) linkages improve stability and influence protein interactions, but do not inherently confer SNP specificity.

Higher affinity is not always higher selectivity: overly stable binding to both alleles can narrow the discrimination window.

ASO approach Intended outcome Allele-selective design consideration
Gapmer ASO Preferential RNase H1-mediated degradation of the variant transcript Evaluate mismatch placement relative to the DNA gap, modified wings, and RNase H cleavage; measure knockdown of both alleles.
Steric-Blocking ASO Preferential interference with translation or RNA interactions without RNase H cleavage Optimize affinity and mismatch sensitivity while confirming the intended functional blocking mechanism.
Splice-Switching ASO Allele-biased exon inclusion, skipping, or splice-site modulation where sequence context permits Assess variant proximity to the regulatory splice element and quantify allele-specific splice isoforms.

Design & Target Accessibility

  • Align mutant and wild-type transcript sequences and confirm the exact variant position.
  • Screen several ASO lengths, target windows, and mismatch positions rather than relying on a single candidate.
  • Consider local RNA secondary structure, transcript isoforms, and RNA-binding proteins.
  • Balance binding affinity, selectivity, nuclease resistance, and the required mechanism.

Recommended Experimental Controls

  • Matched wild-type and variant RNA targets or cell models.
  • Non-targeting ASO and, where useful, a mismatch-control ASO.
  • Dose-response and time-course measurements for both alleles.
  • Allele-resolved RNA or protein readouts, with viability and off-target assessments as appropriate.

Custom allele-selective ASO projects: Bio-Synthesis can discuss synthesis of candidate sequences with selected LNA, 2′-MOE, 2′-OMe, and PS modification patterns, along with purification and analytical QC options. Share the reference and variant target sequences, intended mechanism, quantity, and required controls when requesting a quote. Allele discrimination and biological activity require application-specific validation.

Oligonucleotide Modifications Used in ASO Design

Looking for a specific ASO modification?
The table below shows common ASO chemistries only. Bio-Synthesis supports thousands of advanced and exotic modifications across base, sugar, backbone, and linkage designs.

Contact us or request a quote for specialized ASO synthesis.

Modification Type Primary Function Best Use Key Advantage
Phosphorothioate (PS) Backbone stabilization and nuclease resistance Gapmer ASO, steric-blocking ASO, and SSO designs Improves oligo stability and supports in vivo-oriented ASO workflows
2′-O-Methyl (2′-OMe) RNA affinity and stability enhancement Steric-blocking ASO and splice-switching ASO Improves duplex stability while supporting non-cleaving mechanisms
2′-O-Methoxyethyl (2′-MOE) Higher binding affinity and improved pharmacokinetic properties Gapmer wings, steric-blocking ASO, and therapeutic-style ASO designs Widely used in advanced ASO designs requiring stability and potency
2′-Fluoro (2′-F) Affinity tuning and duplex stabilization Hybrid ASO designs and selected RNA-targeting applications Enhances binding strength and can be combined with other chemistries
LNA / BNA High-affinity binding and mismatch discrimination Gapmer wings, short ASOs, and high-specificity designs Enables stronger target binding with shorter oligo designs
cEt / Constrained Ethyl High-affinity wing chemistry Advanced gapmer and therapeutic-style ASO designs Supports potent RNA binding and durable activity in optimized designs
Morpholino / PMO Non-natural backbone for steric blocking Steric-blocking ASO and splice-switching ASO Does not activate RNase H and is well suited for splice modulation
Conjugates Delivery, targeting, or detection enhancement GalNAc, cholesterol, peptides, lipids, fluorophores, and biotin labeling Supports targeted delivery, tracking, purification, and functional assay needs

Need a modification not shown here?
The modifications listed above are only common examples. Bio-Synthesis supports thousands of exotic and custom base, sugar, backbone, and linkage modifications. If you do not see the exact modification you need, contact us or request a quote — our team can support highly specialized ASO designs.

Custom Synthesis Options

Bio-Synthesis offers flexible ASO synthesis tailored to research, translational, and development-stage projects.

Design & Chemistry

  • Custom sequence synthesis
  • Gapmer, steric-blocking, and splice-switching designs
  • Backbone, sugar, base, linkage, and terminal modifications
  • Standard and advanced modification patterns

Scale & Purification

  • Research to development-scale synthesis
  • Project support up to 100 g/batch
  • HPLC and PAGE purification options
  • Salt exchange, desalting, and lyophilization support

Quality Control

  • Mass spectrometry confirmation
  • Analytical HPLC
  • OD260 quantification
  • Custom release testing upon request

Quality System Support

  • ISO 9001:2015 / ISO 13485:2016
  • GLP/GMP-aligned project support
  • U.S.A. facilities in Texas
  • 45+ years of oligonucleotide expertise

Optional Add-On Services

Custom Formulation & Packaging →

Buffers (TE/PBS/custom), aliquoting, concentrations, tubes or plates, OEM labels/barcodes.

Custom Quality Control →

LC-MS, CE, extended HPLC traces, endotoxin/bioburden, water content, residual chemical analysis, stability program.

Regulatory & OEM →

RUO→GLP→cGMP pathways, document packages, tech transfer, sequence masking.

FAQ

What are the three main ASO product services?
The three core ASO services are Gapmer ASO, Steric-Blocking ASO, and Splice-Switching ASO.
What is the difference between gapmer and steric-blocking ASO?
Gapmers recruit RNase H1 to degrade RNA, while steric-blocking ASOs bind RNA without cleavage and block RNA function or interactions.
Are the listed modifications all Bio-Synthesis offers?
No. The table lists common examples only. Bio-Synthesis supports thousands of advanced base, sugar, backbone, and linkage modifications.
What scale can Bio-Synthesis support?
Projects can be supported from research scale through larger development needs, including up to 100 g/batch depending on sequence, chemistry, and project requirements.

Plan Your Custom ASO Synthesis Project

Discuss gapmer, steric-blocking, splice-switching and allele-specific ASO designs with Bio-Synthesis. Share your target sequence, preferred mechanism, chemical modifications and analytical requirements for a project-specific feasibility review.

From Target Sequence to Custom ASO

Mechanism selection · Chemical modification · Synthesis · Analytical QC

TARGET RNA MODIFIED ASO
01

Sequence & Mechanism Review

Provide the target transcript, species and intended outcome. For allele-specific projects, include both mutant and wild-type sequences with the SNP position.

Target sequence Gapmer / blocking SNP position
02

Modifications & Selectivity

Review LNA, 2′-MOE, 2′-OMe and PS patterns alongside mismatch placement, target accessibility and matched experimental controls.

PS backbone Allele selectivity LNA / MOE / OMe
03

Quantity, Purification & QC

Specify desired scale, purity, analytical testing, delivery format and documentation. Manufacturing feasibility and acceptance criteria are confirmed at quotation.

Scale Purification Analytical QC

For a faster quotation, include the ASO sequence (5′→3′), modification map, required yield and purity, and reference/variant controls where applicable. Allele selectivity requires experimental confirmation.

Scientific Validation & Recommended Reading

Peer-reviewed research that identifies Bio-Synthesis-supplied antisense oligonucleotides, followed by foundational literature on ASO mechanisms and design.

Published Research Using Bio-Synthesis ASO Oligonucleotides

These peer-reviewed studies explicitly identify Bio-Synthesis as a source of antisense oligonucleotides, gapmers or modified antisense materials. Supplier attribution is based on the methods or reagent sections of the original articles.

BNA NC Gapmers Revert Splicing and Reduce RNA Foci with Low Toxicity in Myotonic Dystrophy Cells

ACS Chemical Biology. The methods identify Bio-Synthesis as the supplier of BNA NC antisense gapmers evaluated in myotonic dystrophy cell models.

Read publication →

Enhanced Protein Precipitation with Ammonia Enables Rapid, Universal Extraction of Oligonucleotides for Bioanalysis

The methods state that all ASO and siRNA materials used in the study were designed in-house by the researchers and synthesized by Bio-Synthesis; identity and purity were verified by LC-MS.

Read publication →

Antisense Oligonucleotide and Thyroid Hormone Conjugates for Obesity Treatment

The methods identify Bio-Synthesis as the supplier of thiol- and amino-linker-functionalized phosphorothioate ASOs used to prepare experimental ASO–T3 conjugates. The final conjugation was described by the study authors.

Read publication →

Gene-Specific Nonsense-Mediated mRNA Decay Targeting for Cystic Fibrosis Therapy

The methods identify Bio-Synthesis as the supplier of 18-mer ASOs bearing 2′-MOE sugar, phosphorothioate backbone and 5-methylcytosine modifications. Other ASO lengths came from other suppliers.

Read publication →

Publication attribution refers only to the specific materials described in each article. It does not establish that Bio-Synthesis manufactured all study reagents, performed the experiments, or guarantees comparable biological outcomes.

Foundational ASO Mechanisms & Design Literature

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.